Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease

被引:0
|
作者
Broussy, Sylvain [1 ]
机构
[1] Univ Paris C, UMR CNRS 8038, U1268 INSERM, CiTCoM,UFR Pharm Fac Sante, F-75006 Paris, France
关键词
D O I
10.3390/ph17070959
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Vascular Endothelial Growth Factor (VEGF) and Prostate Pathology
    Botelho, Francisco
    Pina, Francisco
    Silva, Pedro
    Figueiredo, Gabriela
    Cruz, Francisco
    Lunet, Nuno
    [J]. INTERNATIONAL BRAZ J UROL, 2010, 36 (04): : 430 - 437
  • [42] Vascular Endothelial Growth Factor (VEGF) in Neurodevelopmental Disorders
    Howell K.R.
    Armstrong J.
    [J]. Current Behavioral Neuroscience Reports, 2017, 4 (4) : 299 - 308
  • [43] Vascular endothelial growth factor (VEGF) and its receptors
    Neufeld, G
    Cohen, T
    Gengrinovitch, S
    Poltorak, Z
    [J]. FASEB JOURNAL, 1999, 13 (01): : 9 - 22
  • [44] Vascular endothelial growth factor (VEGF) in ankylosing spondylitis
    Duftner, C
    Dulak, J
    Goldberger, C
    Weidlinger, F
    Falkenbach, A
    Schirmer, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 239 - 239
  • [45] Vascular endothelial growth factor (VEGF) & tumour angiogenesis
    Moulik, Shuvojit
    Chafterjee, Amitava
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2007, 125 (06) : 715 - 716
  • [46] Placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) in inflammatory skin disease
    Young, HS
    Janes, L
    Plant, D
    Worthington, J
    Griffiths, CEM
    Detmar, MJ
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [47] Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behcet's uveitis
    Sertoglu, Erdim
    Yucel, Cigdem
    Omma, Ahmet
    Hayran, Yildiz
    Colak, Seda
    Sandikci, Sevinc Can
    Durukan, Ali Hakan
    Ozgurtas, Taner
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (03): : 231 - 240
  • [48] THROMBOEMBOLIC EVENTS FOLLOWING INTRAOCULAR INJECTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)-INHIBITORS
    McKnight, Charlotte
    Kemp, Anna
    Preen, David
    Morlet, Nigel
    Clark, Antony
    McAllister, Ian
    Sanfilippo, Frank
    Ng, Jonathon
    Reynolds, Wayne
    Mark, Gilles
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 33 - 34
  • [49] Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors
    Schlaeppi, JM
    Wood, JM
    [J]. CANCER AND METASTASIS REVIEWS, 1999, 18 (04) : 473 - 481
  • [50] Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors
    Jean-Marc Schlaeppi
    Jeanette M. Wood
    [J]. Cancer and Metastasis Reviews, 1999, 18 : 473 - 481